CVE:ZYU ZYUS Life Sciences (ZYU) Stock Price, News & Analysis → This military-backed stock “owns” AI market (From Porter & Company) (Ad) Free ZYU Stock Alerts Add Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsHeadlinesStock AnalysisAnalyst ForecastsChartEarningsHeadlines Get ZYUS Life Sciences alerts: Email Address Ad Weiss RatingsWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.I call these Nvidia’s “Silent Partners.” About ZYUS Life Sciences Stock (CVE:ZYU)Read More Ad Weiss RatingsWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.I call these Nvidia’s “Silent Partners.” ZYU Stock News HeadlinesMay 29, 2024 | msn.comSymbiosis study exposes new 'origin' theories, identifies experimental systems for plant lifeMay 13, 2024 | markets.businessinsider.comLeading Life Science Companies eLabNext and Zifo Forge Strategic Partnership to Revolutionize Laboratory DigitizationMay 8, 2024 | finance.yahoo.comINSERTING and REPLACING ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9May 7, 2024 | finance.yahoo.comZYUS Announces Completion of Its Annual FilingsMay 5, 2024 | msn.comCOEUS Solutions Rebrands as BridgeView Life Sciences to Amplify Support for Life Sciences SectorMay 1, 2024 | msn.comThis Chinese virologist shared crucial Covid-19 data. Then his research hit hurdlesApril 30, 2024 | tmcnet.comCOEUS Solutions Rebrands as BridgeView Life Sciences After Successful SpinoffApril 29, 2024 | finance.yahoo.comZYUS Announces Anticipated Delay in Its Annual FilingsApril 25, 2024 | msn.comLive Science daily newsletter: Get amazing science every dayApril 25, 2024 | msn.comMore than 100 life science exhibits on display in AlachuaApril 23, 2024 | finance.yahoo.comZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain ManagementApril 19, 2024 | highschool.latimes.comArtificial blood: Life saving scienceApril 12, 2024 | msn.comThis N.J. high school is in the running for $100K science prizeApril 11, 2024 | msn.com'It's amazing': Orlando Science Center opens new 'Life' exhibit with multiple ecosystems to exploreApril 10, 2024 | bizjournals.comLife sciences hub in Holly Springs to expand with land dealApril 8, 2024 | msn.comIt's a dazzling day for science as eclipse brings researchers of all ages to Akron ZooMarch 28, 2024 | msn.comMzansi learners participate in Beijing science expoMarch 27, 2024 | bbc.co.ukPrimary ScienceMarch 8, 2024 | msn.comStartup Boundless Bio files to go public — San Diego’s first life science IPO of 2024February 26, 2024 | time.comScience: BeebeFebruary 26, 2024 | finance.yahoo.comPositive Signs As Multiple Insiders Buy ZYUS Life Sciences StockFebruary 22, 2024 | msn.comStarving mosquitoes for scienceFebruary 19, 2024 | finance.yahoo.comZYUS Life Sciences Corporation (ZLSCF)See More Headlines Receive ZYU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ZYUS Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/07/2024Today6/02/2024Next Earnings (Estimated)9/03/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE SectorN/A Industry N/A Sub-IndustryN/A Current SymbolCVE:ZYU CUSIPN/A CIKN/A WebN/A PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableN/A BetaN/A Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report ZYU Stock Analysis - Frequently Asked Questions Should I buy or sell ZYUS Life Sciences stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ZYUS Life Sciences in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ZYU shares. View ZYU analyst ratings or view top-rated stocks. When is ZYUS Life Sciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, September 3rd 2024. View our ZYU earnings forecast. How were ZYUS Life Sciences' earnings last quarter? ZYUS Life Sciences Corporation (CVE:ZYU) announced its quarterly earnings data on Tuesday, May, 7th. The company reported ($0.03) earnings per share for the quarter. The firm earned $0.10 million during the quarter. How do I buy shares of ZYUS Life Sciences? Shares of ZYU stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:ZYU) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe Worst is Yet to Come…Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZYUS Life Sciences Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
